Overview

Epredia is a global leader in the field of anatomical pathology, providing comprehensive solutions for precision cancer diagnostics with the goal of contributing to better outcomes for patients.
Anatomical pathology involves observing organs and tissues and diagnosing whether tissues are benign or malignant, and is essential for cancer diagnostics and treatment. A collected tissue specimen goes through many processing steps in a pathology lab before being placed on a glass slide for observation and diagnosis, and Epredia offers a wide range of products to make the laboratory workflow more efficient and effective. Known for product brands such as Shandon, Richard-Allan Scientific, Microm, and Menzel Glaser, the company has been providing solutions for precision cancer diagnostics since its founding in 1937.
Currently, 48 Epredia products are used every second in medical institutions and research facilities around the world. We will continue to drive innovation to help improve the lives of cancer patients worldwide.

Strengths

• Comprehensive, state-of-the-art technology for laboratories
  Epredia provides high-quality instrumentation and consumables necessary for pathology laboratories working with tissue samples. Key products include glass microscope slides that are recognized for their excellent adhesion quality and exceptional clarity. Each piece of equipment is designed with pathologists’ needs in mind such as ergonomics and ease of use, with the goal of contributing to efficient and accurate cancer diagnosis for the patient.
• Innovative products powered by digital technology
  Typically, specimens prepared on glass slides are observed by pathologists using a microscope, but in recent years digital pathology technology has emerged in which tissue specimens can be scanned as digital images and viewed on a computer screen. Technology may soon be developed to use AI image recognition to analyze these digital images to support cancer　diagnostics. Epredia is offering AI solutions to our customers through our partnership with companies Paige and Aiforia.
• Strong customer base and high market share
  Epredia has trusted relationships with customers and a high market share that has been cultivated over the last 85 years. In particular, we are often viewed as the worldwide leader for microscope slides and tissue processors.

Main Products/Services

• Slide Glass
  High-quality pathological diagnosis requires high-quality microscope slides. Our unique glass manufacturing technology enables smooth surfaces and uniform thickness, supporting high-quality specimen analysis and highly accurate diagnosis.
• Pathology Reagents
  Cytology staining, which provides clear contrast between cytoplasm and nuclear chromatin, is an important component in cancer diagnostics. Epredia’s staining equipment is designed to stain tissue samples with high transparency and sharpness, and can be used in combination with a variety of staining solutions.
• Pathology Equipment
  Tissue processing is critical to obtaining reliable results in the histology laboratory. Laboratories are under pressure to speed up processes, reduce costs, and prevent operational errors. Epredia’s tissue processing solutions are designed to efficiently produce high-quality paraffin blocks to enable pathologists to make an accurate diagnosis.
• Labeling and Management Solutions
  To prevent operational errors in the histology laboratory, cassettes and microscope slides must be labeled, properly recorded, and tracked. Epredia’s cassette printers and slide printers with laser technology and on-demand printing capabilities provide an automated way of labeling and tracking laboratory samples and slides, to increase accuracy while streamlining workflow.

• Slide Glass

  Achieve more accurate diagnosis with the highest level of optical clarity.

  

• Pathology Reagents

  Streamline microscopic observation of cytoplasm and chromatin with a highly transparent and cost-effective staining solution.

  

• Pathology Equipment

  Streamline the work of applying reagents to samples and reduce reagent costs.

  

• Labeling Solutions

  Automate printing of slides and cassettes to streamline workflow.

  

• Digital Pathology

  Contributing to the future of digital pathology solutions through partnership with 3DHISTECH.

  

* In-house research

Epredia（Pathology Division）

The number of cancer diagnoses is increasing worldwide, and as a result, cancer-related drug development activities are expanding, especially among pharmaceutical companies. In this environment, the market for pathology testing equipment and consumables is expected to grow at a mid-single-digit rate.
We are focusing on the areas of digital pathology and immunohistochemical staining. Digital pathology supports cancer diagnostics using digital images rather than a microscope. Additionally, when it is necessary to confirm what kinds of proteins are distributed in cells and tissues, a technique called immunohistochemical staining is used. These technologies are attracting attention for their potential to greatly improve the efficiency of cancer diagnostics and pharmaceutical research and development, and are expected to grow by double digits annually.
Pathology is an area where high quality and stability are especially critical, and we will continue to develop new high-quality products and seek to increase our market share.
Additionally, in the growing field of digital pathology, we offer digital pathology products including those made by our partner 3DHISTECH. As a partner in immunohistochemical staining with 3DHISTECH, we jointly operate a research and development laboratory, the Pathology Innovation Incubator (Pi2), and we will invest heavily in the growth of digital pathology and immunohistochemical staining.

The E1000 Dx^™ Digital Pathology Solution, developed from a practitioner's perspective and based on the experience and knowledge of physicians, is now available in the UK. The scanner can load up to 1,000 slides at once and automatically scan them in about half a day.
Scanning during the night and sharing the data among pathologists the next day, for example, enables high volume and rapid observation irrespective of the pathologist's location. This contributes to making the diagnostics process more efficient.